In particular, the authors found that Tim-3, in addition to being expressed on the cell types previously considered, can also be expressed on endothelial cells after stimulation with Toll-Like Receptor 4 (TLR4) ligand released by tumour cells. This evidence concerns the gene HAVCR2 and neoplasm.